Vaccines for epidemic infections and the role of CEPI.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. rLVS ΔHuman vaccines & immunotherapeutics · 2025
   Article
2. Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease.Vaccines · 2023
   Article
3. Antimicrobial and Virucidal Potential of Morpholinium-Based Ionic Liquids.International journal of molecular sciences · 2023
   Article
4. Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection.Methods in molecular biology (Clifton, N.J.) · 2023
   Article
5. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies.Journal of microbiology (Seoul, Korea) · 2022
   Review
6. COVID-19 vaccines: Frequently asked questions and updated answers.Infectious diseases now · 2021
   Review
7. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.bioRxiv : the preprint server for biology · 2021
   Article
8. Evolving pharmacovigilance requirements with novel vaccines and vaccine components.BMJ global health · 2021
   Review
9. NIH funding for vaccine readiness before the COVID-19 pandemic.Vaccine · 2021
   Article
10. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.Human vaccines & immunotherapeutics · 2021
    Article
11. The Constant Threat of Zoonotic and Vector-Borne Emerging Tropical Diseases: Living on the Edge.Frontiers in tropical diseases · 2021
    Article
12. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?The Lancet. Infectious diseases · 2020
    Article
13. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.Scientific reports · 2020
    Article
14. The New Coronavirus, the Current King of China.Journal of the Pediatric Infectious Diseases Society · 2020
    Article
15. Impact of Vaccines; Health, Economic and Social Perspectives.Frontiers in microbiology · 2020
    Review
16. Emerging Concepts and Technologies in Vaccine Development.Frontiers in immunology · 2020
    Review
17. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.Frontiers in immunology · 2020
    Review
18. COVID-19 and Private Health: Market and Governance Failure.Development (Society for International Development) · 2020
    Article
19. Poliopolis: pushing boundaries of scientific innovations for disease eradication.Future microbiology · 2019
    Article
20. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.Viruses · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as